Integer (NYSE:ITGR) Hits New 1-Year High – Should You Buy?

Integer Holdings Co. (NYSE:ITGR) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $142.76 and last traded at $141.54, with a volume of 16683 shares changing hands. The stock had previously closed at $141.16.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ITGR. Truist Financial dropped their price target on Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Citigroup lifted their price target on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday. Benchmark lifted their price target on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. Finally, KeyCorp lifted their target price on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $142.00.

Integer Trading Down 1.1 %

The business has a 50-day simple moving average of $131.87 and a two-hundred day simple moving average of $124.78. The stock has a market cap of $4.68 billion, a price-to-earnings ratio of 43.55, a P/E/G ratio of 1.99 and a beta of 1.12. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.27 earnings per share. Equities analysts forecast that Integer Holdings Co. will post 5.33 EPS for the current fiscal year.

Hedge Funds Weigh In On Integer

A number of institutional investors have recently bought and sold shares of ITGR. Driehaus Capital Management LLC boosted its holdings in shares of Integer by 62.5% during the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after acquiring an additional 135,750 shares during the period. Eagle Asset Management Inc. bought a new stake in shares of Integer during the third quarter worth approximately $14,403,000. F M Investments LLC bought a new stake in shares of Integer in the second quarter valued at approximately $11,143,000. Point72 Europe London LLP bought a new stake in shares of Integer in the second quarter valued at approximately $6,241,000. Finally, Bamco Inc. NY boosted its stake in shares of Integer by 17.4% in the third quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider’s stock valued at $33,069,000 after buying an additional 37,700 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.